Remove tag pharmacovigilance
article thumbnail

Pioneering the Path Pre- and Post-Launch Strategies

PM360

Through initiatives such as post-marketing surveillance, pharmacovigilance, and medical education programs, Medical Affairs teams are committed to ongoing monitoring and support to ensure the safe and effective use of medications.

Medical 52
article thumbnail

Realising milestones with gene therapy for SMA

European Pharmaceutical Review

1 This is assuming a $1M price tag for all gene therapies. What are the emerging modalities in the gene therapy sector? By 2030, 20-25 gene therapies are expected to reach market approval, accounting for 1.30-1.61 percent of Europe’s annual healthcare spend. In reality, this will vary by disease area and therapy.